← Back to Search

Health Support Interventions for Blood Pressure Control

N/A

Waitlist Available

Led By Francesca Gany, MD, MS

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Male

Speaks English, Spanish, Bengali, Urdu, or French

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9 months

Awards & highlights

Study Summary

This trial is studying the best way to help truck drivers who have high blood pressure and are at risk for cancer. They will be given health screenings and consultations to help them maintain a healthy weight and increase cancer screenings.

Who is the study for?

This trial is for male taxi drivers over 19 years old in NYC with high blood pressure, who plan to stay in the city for at least 9 months. They must have a cell phone capable of receiving texts and speak English, Spanish, Bengali, Urdu, or French. Part-time drivers and those with cardiovascular diseases other than hypertension are excluded.Check my eligibility

What is being tested?

The study tests different follow-up methods after Health Fairs to manage high blood pressure and reduce cancer risk among taxi drivers. It compares usual health fair follow-ups with additional tech support like text messaging and home monitoring plus social network support.See study design

What are the potential side effects?

Since this trial focuses on technology-based interventions rather than medications, traditional side effects are not a concern. However, participants may experience stress or anxiety from constant health monitoring or technical issues with devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

The study is only open to male participants.

Select...

You can speak English, Spanish, Bengali, Urdu, or French.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

decrease in blood pressure levels

Trial Design

3Treatment groups

Experimental Treatment

Group I: Health Fairs (HF)Experimental Treatment1 Intervention

Drivers will undergo U&C Health Fair follow-up either Regular or Urgent Follow-up: Timeline is determined by health status, with regular follow-up continuing for at least two weeks and urgent follow-up continuing for at least a month

Group II: HF +Tech + social network support (SNS).Experimental Treatment1 Intervention

Drivers will receive: U&C HF follow-up, Mobile text messaging intervention w/ interactive 2- way messaging to encourage BP management for nine months and home BP monitoring equipment with instructions to self-monitor BP for nine months A social network support intervention in which selected family/peers encourage drivers to maintain healthy behaviors for nine months

Group III: HF + text messaging + home BP monitoringExperimental Treatment1 Intervention

Drivers will receive: U&C HF follow-up, Mobile text messaging intervention w/ interactive 2- way messaging to encourage BP management for nine months A home BP monitoring equipment with instructions to self-monitor BP for nine months

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,456 Total Patients Enrolled

Francesca Gany, MD, MSPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

8 Previous Clinical Trials

2,989 Total Patients Enrolled

Media Library

CONTROL- Usual & Customary Health Fair Follow-up Clinical Trial Eligibility Overview. Trial Name: NCT02701829 — N/A

Blood Pressure Control Research Study Groups: Health Fairs (HF), HF + text messaging + home BP monitoring, HF +Tech + social network support (SNS).

Blood Pressure Control Clinical Trial 2023: CONTROL- Usual & Customary Health Fair Follow-up Highlights & Side Effects. Trial Name: NCT02701829 — N/A

CONTROL- Usual & Customary Health Fair Follow-up 2023 Treatment Timeline for Medical Study. Trial Name: NCT02701829 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for patients to enroll in this research endeavor?

"According to the information present on clinicaltrials.gov, this medical trial is not actively seeking participants; however, it was last edited in December 2021. There are still 1 other trials recruiting candidates at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support

2016. "Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02701829.